Companies

Bristol Myers Squibb

PharmaceuticalsPrinceton, New JerseyBMYAbout 32,500 employees

WorkHush has 3 source-backed updates on Bristol Myers Squibb workforce changes since February 2026. The latest, added September 22, 2026: 265 jobs in September 2026 New Jersey WARN notice (Princeton) (WARN notice). Layoffs are under way until December 31, 2026. Read it with sources ›

265 jobs in September 2026 New Jersey WARN notice (Princeton)

WARN notice · New Jersey WARN notice posted September 2026; effective December 17, 2026 to May 21, 2027

Sources: New Jersey Department of Labor WARN report, Fierce Pharma, NJBIZ

Layoffs under way untilDec 31206 jobs in April 2026 New Jersey WARN notice (Lawrence Township)
More about Bristol Myers Squibb

Drugmaker that develops and sells prescription medicines for cancer, blood disorders, immune diseases, heart disease and mental illness

Revenue
$48.2B
Fiscal 2025, roughly flat
Employees
About 32,500
As of December 2025
Stock
BMY
New York Stock Exchange
Headquarters
Princeton, New Jersey
CEO
Christopher Boerner
Since 2023
BrandsOpdivo, Eliquis, Revlimid, Cobenfy, Camzyos, Breyanzi
Current strategyCutting about $2B in costs by 2027 to offset patent expirations while building newer drugs
Recent workforce changes718 New Jersey jobs cut in 2026, in rounds announced in February, April and September (265)
CompetitorsMerck, Pfizer, AbbVie
Related companiesMerckPfizerAbbVie

Checked October 11, 2026 · Sources: sec.gov, thesunpapers.com

Be the first to post about Bristol Myers Squibb

No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.

Or follow Bristol Myers Squibb to see the first post in your watchlist.

Follow Bristol Myers Squibb in a feed reader, no account needed: RSS feed